Trevor McGill, PhD
Over the last 15 years, my research has been focused on the evaluation of cell and gene therapies for retinal degenerative disease, and the translation of these therapies from small experimental animals into non-human primates. In collaboration with two biotech companies, we have succeeded in gaining FDA approval for two independent Phase I/II clinical trials. I continue this line of research as such, and I currently am the principal investigator on multiple projects involving translational studies involving cell or gene therapy-. Due to my success in this translational field, I was recently awarded the prestigious Carl Camras Translation Research Award at the Association for Research in Vision and Ophthalmology (2015). Over the past six years, my research has focused more heavily on the non-human primate as a model system for examining mechanisms of retinal disease and development and evaluation of prospective cell and gene therapies in this model.